Nachrichten zur Edwards Lifesciences Corp Aktie

BD Stock Falls After Acquisition of Edwards Critical Care Group

BDX expands its smart care portfolio by acquiring Edwards Lifesciences Critical Care group, now BD Advanced Patient Monitoring, strengthening AI-driven…

Should You Hold Edward Lifesciences (EW) in Your Portfolio Now?

Edward Lifesciences (EW) promising TAVR business and the Critical Care divestment move bode well in the long term.…

Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash

Edwards Lifesciences (EW) reports strong contributions from the TMTT product group in the second quarter of 2024.…

After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more By Investing.com

After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more…

Edwards Lifesciences Crumbles On Slashed TAVR Outlook

The company now expects full-year sales in its TAVR division to climb 5% to 7%.…

Edwards Lifesciences (EW) Buys Innovalve to Boost TMVR Solutions

Edwards Lifesciences (EW) exercises the option to acquire Innovalve Bio-Medical Ltd., strengthening its TMVR technology portfolio and addressing unmet…

Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings?

Edwards Lifesciences (EW) TMTT segments PASCAL platform is likely to have maintained strong growth momentum in the second quarter…

Edwards Lifesciences: Focus On The Heart

…

Aktienmarkt: Edwards Lifesciences-Aktie tritt auf der Stelle (85,6517 €)

Wenig Kursbewegung aktuell bei dem Anteilsschein von Edwards Lifesciences . Das Papier kostete zuletzt 91,47 US-Dollar. Die Wertschätzung der Investoren…

Edwards Lifesciences Corp Looks Bullish (Technical Analysis)

…

Edwards Lifesciences Stock Jumps On Surprise $4.2 Billion Deal

Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinsons plan to buy a key division for $4.2 billion.…

Edwards Lifesciences exec sells shares worth over $73k By Investing.com

Edwards Lifesciences exec sells shares worth over $73k…

Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)

…

The Zacks Analyst Blog Highlights Salesforce, BP, The Southern, PayPal and Edwards Lifesciences

Salesforce, BP, The Southern, PayPal and Edwards Lifesciences are included in this Analyst Blog.…

Earnings call: Edwards Lifesciences sees robust Q1 growth, raises guidance By Investing.com

Earnings call: Edwards Lifesciences sees robust Q1 growth, raises guidance…

Edwards Lifesciences stock maintains $100 target and Buy rating By Investing.com

Edwards Lifesciences stock maintains $100 target and Buy rating…

Global Cardiovascular Surgical Devices Market Expected to Surge to US$ 2.77 Billion by 2032 - Technological Innovations and Approvals Boosting the Market

Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Cardiovascular Surgical Devices Market, Size, Share, Global Forecast 2024-2032, Industry…

Edwards Lifesciences exec sells over $1.1m in company stock By Investing.com

Edwards Lifesciences exec sells over $1.1m in company stock…

Edwards Lifesciences executive sells over $2.7 million in stock By Investing.com

Edwards Lifesciences executive sells over $2.7 million in stock…

Edwards Lifesciences Corporations (NYSE:EW) Stock Is Going Strong: Is the Market Following Fundamentals?

Edwards Lifesciences (NYSE:EW) has had a great run on the share market with its stock up by a significant 23%…

Edwards Lifesciences shares target raised by Oppenheimer on valve therapy outlook By Investing.com

Edwards Lifesciences shares target raised by Oppenheimer on valve therapy outlook…

Edwards Lifesciences (EW) Hits 52-Week High: Whats Driving It?

Edwards Lifesciences (EW) outperforms the industry, owing to a robust 2023 fourth-quarter performance, as well as the strong potential in…

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day

Shares of Edwards Lifesciences Corp. rose 2.22% to $92.93 Wednesday, on what proved to be an all-around mixed trading session…

Edwards Lifesciences (EW) SAPIEN TAVR Study Outcome Favorable

Edwards Lifesciences (EW) recent study provides insights into the actual performance of small Edwards valves and reaffirms the excellent outcomes…

Edwards Lifesciences stock upgraded to buy, PT lifted to $105 By Investing.com

Edwards Lifesciences stock upgraded to buy, PT lifted to $105…

Edwards Lifesciences (EW) Wins FDA Nod for the EVOQUE System

Edwards Lifesciences (EW) EVOQUE valve replacement system becomes the first transcatheter therapy to earn FDA approval for a tricuspid valve.…

FDA approves Edwards Lifesciences EVOQUE valve system By Investing.com

FDA approves Edwards Lifesciences EVOQUE valve system…

Whats in Store for Edwards Lifesciences (EW) in Q4 Earnings?

Edwards Lifesciences (EW) Q4 results are likely to reflect continued demand for its state-of-the-art HemoSphere monitoring platform and Smart Recovery…

Edwards Lifesciences: Undervalued With A Substantial Upside Potential

…

Edwards Lifesciences (EW) Forwards Growth Strategy and Outlook

Edwards Lifesciences (EW) TAVR remains strong, driven by greater awareness, patient activation and advances in new technologies such as RESILIA.…

: Edwards Lifesciences to spin off Critical Care unit, sets $1B stock buyback

Edwards Lifesciences Corp.’s stock EW rose 1.9% in premarket trading Thursday after it said it plans to form an…

Edwards Lifesciences stock dips, ending four-day rally as market declines By Investing.com

Edwards Lifesciences stock dips, ending four-day rally as market declines…

Edwards Lifesciences cut by Wolfe Research on risk of US TAVR disappointing By Investing.com

Edwards Lifesciences cut by Wolfe Research on risk of US TAVR disappointing…

Edwards Lifesciences Q3: Clinical Trial Updates Impress

…

Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets

…

Edwards Lifesciences tumbles as guidance misses expectations By Investing.com

Edwards Lifesciences tumbles as guidance misses expectations…

Edwards Lifesciences (EW) Q3 Earnings Match Mark, Margins Dip

Edwards Lifesciences (EW) TMTT performance benefits from the accelerated adoption of the differentiated PASCAL precision platform in the third quarter.…

Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include PepsiCo (PEP), The J.M.…

Whats in Store for Edwards Lifesciences (EW) in Q3 Earnings?

Outside the United States, Edwards Lifesciences (EW) TAVR sales growth will likely be driven by broad-based adoption of the SAPIEN…

Edwards Lifesciences said to be the target of EU antitrust raid last week

…

Oppenheimer sees exciting opportunity for Edwards Lifesciences By Investing.com

Oppenheimer sees exciting opportunity for Edwards Lifesciences…

Edwards Lifesciences (EW) Down 9.3% Since Last Earnings Report: Can It Rebound?

Edwards Lifesciences (EW) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Edwards Lifesciences (EW) Rides on TAVR Amid Rise in Costs

Edwards Lifesciences (EW) Surgical Structural Heart business growth is driven by increased penetration of its premium RESILIA products across all…

Analyst Ratings for Edwards Lifesciences

Latest Ratings for EW DateFirmActionFromTo Feb 2022UBSUpgradesNeutralBuy Jan 2022Morgan StanleyMaintainsOverweight Jan 2022Raymond JamesMaintainsOutperform View More…